eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer
Jacob A. Boyer, Ezra Y. Rosen, Malvika Sharma…·Neal X. Rosen
This paper identifies eIF4A as a key regulator of ER translation in breast cancer and shows that inhibiting eIF4A, either alone or with fulvestrant, suppresses ER expression and tumor growth in advanced ER+ breast cancer.